Relmada Therapeutics, Inc.
Pharmaceutical Preparations · Coral Gables, FL, United States
- PrincipalsMaged ShenoudaChief Financial OfficerPaul Edward KellyCOOSergio TraversaChief Executive Officerand 4 more
- CompanyRelmada Therapeutics, Inc.Coral Gables, FL, United States
- Phone line+1 (646) 876-3459General business
Relmada Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker RLMD) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 7
Chief executive
Sergio TraversaChief Executive Officer
Chair & board
Charles J CasamentoDirector (Board)
Fabiana FedeliDirector (Board)
John GlasspoolDirector (Board)
Finance
Maged ShenoudaChief Financial Officer
Operations
Everyone else on file (1)
Chuck EnceCA and CO
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Maged Shenouda — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Paul Edward Kelly — COO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sergio Traversa — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Chuck Ence — CA and CO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Mereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capability